KYNB
Kyntra Bio·NASDAQ
--
--(--)
--
--(--)
6.17 / 10
Outperform
Analyst consensus is overwhelmingly bullish (100% Strong Buy) despite a recent 5.9% price decline. Fund‑flow score is 7.29 (good) with moderate inflow ratios (~45%) but negative trends across all size segments. Sentiment remains positive, supporting a mildly optimistic view.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-09-24
InstitutionHC Wainwright & Co.
Times predicted2
Historical Win Rate50.0%
Is money flowing into or out of KYNB?
- KYNB holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.17/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
